Medicinal cannabis champion to chair new Advisory Council

Medicinal Cannabis Industry Australia (MCIA) is delighted to welcome Dr Richard Di Natale as the inaugural chair of the newly established Healthcare Practitioner/Patient Advisory Council.

“Richard has been a great champion of medicinal cannabis access for patients and will provide invaluable guidance as chair of this unique and important Advisory Council” said Peter Crock Chair of MCIA.

Continue reading “Medicinal cannabis champion to chair new Advisory Council”

MCIA pursues better patient access for down scheduled CBD

In responding to the Therapeutic Goods Administration’s (TGA) interim decision in relation to cannabidiol (CBD) to down-schedule CBD medicines to S3, or pharmacist-only, medicines at appropriate dosage levels, Medicinal Cannabis Industry Australia (MCIA) has recommended further change to the proposed scheduling to ensure that there is an effective pathway for S3 CBD products.

Medicinal cannabis has an important role to play in improving health outcomes. MCIA supports down- scheduling of CBD to S3, which has the potential to provide patients with improved access to a safe low dose cannabis product for medical use.

Continue reading “MCIA pursues better patient access for down scheduled CBD”

MCIA welcomes TGA interim decision to down schedule CBD

Medicinal Cannabis Industry Australia has welcomed the interim decision in relation to cannabidiol (CBD) to down-schedule CBD medicines to S3, or pharmacist-only, medicines.

In the interim decision released today, the Therapeutic Goods Administration (TGA) has supported the down scheduling of CBD to allow greater patient access through enabling registered low-dose CBD products to be available as a Schedule 3 medicine.

Continue reading “MCIA welcomes TGA interim decision to down schedule CBD”

MCIA welcomes new Parliamentary Friends of Medicinal Cannabis Group

Medicinal Cannabis Industry Australia (MCIA) is delighted to welcome the establishment of a Parliamentary Friends of Medicinal Cannabis Group in the Federal Parliament.

The group will provide a non-partisan forum for Members and Senators to meet with representatives of the Australian medicinal cannabis industry, medical experts and patient advocates to raise awareness of the applications of medicinal cannabis to Parliamentarians and within the broader community.

Continue reading “MCIA welcomes new Parliamentary Friends of Medicinal Cannabis Group”

Medicinal Cannabis Industry Australia (MCIA) and Medical Cannabis Council (MCC) collaborate to form a unified voice for the Australian medicinal cannabis industry

MCIA and MCC are pleased to announce that they have entered a collaboration arrangement to create a unified voice for the Australian medicinal cannabis industry.

The Australian medicinal cannabis industry has an important role to play in improving health outcomes for Australian patients. Australia is well placed to lead the world with quality medicinal cannabis, deliver next generation patient well-being, and develop a new export industry.

Continue reading “Medicinal Cannabis Industry Australia (MCIA) and Medical Cannabis Council (MCC) collaborate to form a unified voice for the Australian medicinal cannabis industry”

MCIA welcomes improved patient access to medicinal cannabis

Medicinal Cannabis Industry Australia (MCIA) welcomed the report from The Senate Community Affairs References Committee into Current barriers to patient access to medicinal cannabis in Australia as a key step in assisting patients who are seeking easier and more affordable access to what is a prescription medicine.

Continue reading “MCIA welcomes improved patient access to medicinal cannabis”

An Australian Medicinal Cannabis Conference that will Change the Future.

Early bird tickets on-sale now.

Formed in 2019, Medicinal Cannabis Industry Australia (MCIA) is the peak industry organisation for Australia’s licensed medicinal cannabis industry, with a focus on building an industry that enhances wellbeing through facilitating access to quality Australian medicinal cannabis products for Australian and global patients.

Continue reading “An Australian Medicinal Cannabis Conference that will Change the Future.”

The Future of Medicinal Cannabis Conference Melbourne March 3-4 2020

The Medicinal Cannabis Industry Australia, (MCIA) is launching the inaugural ACannabis Conference to help define and shape the future of the Australian Medicinal Cannabis industry.

The event will draw together all facet of the industries ecosystem to connect, engage and build a framework to support patients’ well-being, enable best practice, and strengthen growth for the industry.

Continue reading “The Future of Medicinal Cannabis Conference Melbourne March 3-4 2020”

MCIA Welcomes the Government’s Support for the Medicinal Cannabis Industry

The Medicinal Cannabis Industry Australia (MCIA) is pleased that Minister Hunt has committed to acting on all 26 recommendations in the McMillan Report on the review of the Narcotic Drugs Act 1967, but seeks further engagement with the Government in relation to the implementation of the report’s recommendations to ensure that the intended outcomes are delivered.

Continue reading “MCIA Welcomes the Government’s Support for the Medicinal Cannabis Industry”

MCIA welcomes the Government’s commitment to growing the medicinal cannabis industry

The Medicinal Cannabis Industry Australia today welcomed the Government’s response to the Narcotic Drugs Act 1967 review which provides commitment to improving the efficiency of the Government regulator and better access to medicinal cannabis products for patients.

Continue reading “MCIA welcomes the Government’s commitment to growing the medicinal cannabis industry”